Biomarkers Predict 30-Year Heart Risk in Women
Conexiant
September 3, 2024
A combined measure of high-sensitivity C-reactive protein, LDL cholesterol, and lipoprotein(a) predicted cardiovascular events in healthy women over 30 years.
The study analyzed data from 27,939 women with a median follow-up of 27.4 years, during which 3,662 major adverse cardiovascular events occurred.
Increasing quintiles of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) were associated with higher 30-year cardiovascular risk.
The greatest risk stratification was achieved by using all three biomarkers in combination, with higher hazard ratios for multiple biomarkers.
The study's limitations included a predominantly White female cohort and the absence of repeated biomarker measurements.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: